Aurobindo Pharma is one of the largest vertically integrated pharmaceutical companies with API integration for over 75% of its products. Over the past few years, the company has drastically shifted its focus from API business to formulations. Hence, the formulations’ share in the total revenues has increased from 54% in FY11 to 79% in FY16.

To read the details report click here.